These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29329042)

  • 1. Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate.
    Behdani F; Roudbaraki SN; Saberi-Karimian M; Tayefi M; Hebrani P; Akhavanrezayat A; Amlashi SV; Ferns GA; Ghayour-Mobarhan M
    Psychiatry Res; 2018 Mar; 261():243-247. PubMed ID: 29329042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
    Samimi M; Jamilian M; Asemi Z; Esmaillzadeh A
    Clin Nutr; 2015 Jun; 34(3):388-93. PubMed ID: 24973862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial.
    Fan X; Copeland P; Nawras S; Harrington A; Freudenreich O; Goff DC; Henderson DC
    Psychopharmacology (Berl); 2019 Jun; 236(6):1949-1957. PubMed ID: 30747254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
    Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 Fatty Acid Could Increase One of Myokines in Male Patients with Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Agh F; Mohammadzadeh Honarvar N; Djalali M; Nematipour E; Gholamhoseini S; Zarei M; Ansari S; Javanbakht MH
    Arch Iran Med; 2017 Jan; 20(1):28-33. PubMed ID: 28112528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine.
    Caniato RN; Alvarenga ME; Garcia-Alcaraz MA
    Aust N Z J Psychiatry; 2006 Aug; 40(8):691-7. PubMed ID: 16866765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program.
    Wu MK; Wang CK; Bai YM; Huang CY; Lee SD
    Psychiatr Serv; 2007 Apr; 58(4):544-50. PubMed ID: 17412858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary supplementation with omega-3 fatty acids and oleate enhances exercise training effects in patients with metabolic syndrome.
    Ortega JF; Morales-Palomo F; Fernandez-Elias V; Hamouti N; Bernardo FJ; Martin-Doimeadios RC; Nelson RK; Horowitz JF; Mora-Rodriguez R
    Obesity (Silver Spring); 2016 Aug; 24(8):1704-11. PubMed ID: 27356240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.
    Henderson DC; Fan X; Sharma B; Copeland PM; Borba CP; Freudenreich O; Cather C; Evins AE; Goff DC
    J Psychiatr Pract; 2009 Jul; 15(4):251-61. PubMed ID: 19625881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial.
    Fleischhacker WW; Heikkinen ME; Olié JP; Landsberg W; Dewaele P; McQuade RD; Loze JY; Hennicken D; Kerselaers W
    Int J Neuropsychopharmacol; 2010 Sep; 13(8):1115-25. PubMed ID: 20459883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
    Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
    Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study.
    Chen CH; Huang MC; Kao CF; Lin SK; Kuo PH; Chiu CC; Lu ML
    J Clin Psychiatry; 2013 May; 74(5):e424-30. PubMed ID: 23759461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
    Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
    Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of desacyl ghrelin in patients with schizophrenia on clozapine monotherapy.
    Wysokiński A; Kowalski ML; Kłoszewska I
    Psychiatry Clin Neurosci; 2014 Dec; 68(12):833-840. PubMed ID: 24773632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Omega-3 PUFAs Supplementation with Lifestyle Modification on Anthropometric Indices and Vo2 max in Overweight Women.
    Haghravan S; Keshavarz SA; Mazaheri R; Alizadeh Z; Mansournia MA
    Arch Iran Med; 2016 May; 19(5):342-7. PubMed ID: 27179166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red Blood Cell Docosapentaenoic Acid (DPA n-3) is Inversely Associated with Triglycerides and C-reactive Protein (CRP) in Healthy Adults and Dose-Dependently Increases Following n-3 Fatty Acid Supplementation.
    Skulas-Ray AC; Flock MR; Richter CK; Harris WS; West SG; Kris-Etherton PM
    Nutrients; 2015 Aug; 7(8):6390-404. PubMed ID: 26247967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    J Diabetes Complications; 2017 Sep; 31(9):1394-1400. PubMed ID: 28716357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
    Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
    Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
    Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
    Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of supplementation with omega-3 on insulin sensitivity and non-esterified free fatty acid (NEFA) in type 2 diabetic patients.
    Farsi PF; Djazayery A; Eshraghian MR; Koohdani F; Saboor-Yaraghi AA; Derakhshanian H; Zarei M; Javanbakht MH; Djalali M
    Arq Bras Endocrinol Metabol; 2014 Jun; 58(4):335-40. PubMed ID: 24936727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.